Last reviewed · How we verify
NCT03684577: WIKI-A
Efficacy of Hypnotherapy for Agoraphobia
NA trial testing Hypnotherapy for Agoraphobia in Agoraphobia in 36 participants. Completed in 29 September 2020.
30 June 2020
Quick facts
| Lead sponsor | University Hospital Tuebingen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 November 2018 |
| Primary completion | 30 June 2020 |
| Estimated completion | 29 September 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Hypnotherapy for Agoraphobia
Conditions studied
- Agoraphobia — all drugs for Agoraphobia →
Sponsor
University Hospital Tuebingen
Who can join
Adults 18 to 65, any sex, with Agoraphobia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to compare the efficacy of Hypnotherapy for the treatment of Agoraphobia compared to a wait-list control group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hypnotherapy for agoraphobia-Feasibility and efficacy investigated in a pilot study.
Fuhr K, Bender A, Wiegand A, Janouch P, et al · · 2023 · cited 1× · PMID 37637902 · DOI 10.3389/fpsyg.2023.1213792
Verify or expand the search:
- PubMed search for NCT03684577
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Agoraphobia
Currently open trials in the same condition.
- NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT06942429 — Stepped Versus Stratified Care for Anxiety Disorders in Youth · NA · recruiting
- NCT06788119 — Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders · NA · recruiting
- NCT05124639 — Clinical Trial of a Group Self-management Support Program for Anxiety Disorders · NA · active not recruiting
Other University Hospital Tuebingen trials
Trials by the same sponsor.
- NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
- NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
- NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
- NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
- NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03684577 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
- Last refreshed: 5 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03684577.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing